Compared side by side

GHK-Cu vs KPV: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

GHK-Cu is a copper-binding tripeptide found naturally in human plasma and widely used in skincare; in cell and animal studies it boosts collagen and speeds wound repair. KPV is also three amino acids long, the tail end of α-MSH, and in cell and mouse studies it calms inflammation by blocking NF-κB inside cells. Commonly reported: smoother skin texture and a more even tone after a month or two of GHK-Cu, and a calmer gut and calmer skin on KPV.

Side by side

ComparedGHK-CuKPV
CategoryHealing & recoveryHealing & recovery
Also known asCopper Peptide, GHK-Copper, Tripeptide-1Lys-Pro-Val, α-MSH tripeptide
What it isA small copper-binding peptide found naturally in your blood and widely used in skincare.One of the smallest bioactive peptides: three amino acids from the tail end of α-MSH.
How it worksTripeptide (glycyl-histidyl-lysine) that binds a copper(II) ion. It occurs naturally in human plasma, and its sequence sits inside type I collagen and the tissue-remodeling protein SPARC. In cell and animal studies, GHK-Cu increased collagen, decorin and glycosaminoglycan production, raised VEGF output by fibroblasts, and damped inflammatory signals such as IL-6. Human evidence is limited to a handful of topical trials, most of them small.C-terminal tripeptide of α-MSH. A potent anti-inflammatory in cell and mouse studies that works mainly inside cells rather than through melanocortin receptors: it enters through the PepT1 transporter and blocks NF-κB signaling. In mice it eased colitis and damped allergic skin reactions; as eye drops it sped corneal wound healing in rabbits; in lab dishes it slowed Staphylococcus aureus and Candida albicans.
Commonly reportedSmoother texture and a more even tone after a month or two. Injected GHK-Cu hasn't been tested in a controlled trial.A calmer gut and calmer skin. No human study has tested it yet.
Studied rangeResearch range: 1–2 mg. Studied in research — not a recommendation.Research range: 100–300 mcg. Studied in research — not a recommendation.
How oftenDailyDaily
Half-lifeNot measured in humans (breaks down quickly in plasma in rat and lab studies)Not measured: no half-life for KPV has been published, in people or animals
RouteSubQ injection, Topical application, IM injectionSubQ injection, Oral
Typical runOften run 8–12 weeks. Can be cycled or run continuously at lower doses. Community consensus is loose.4–8 weeks typical for gut protocols. Can reassess after each cycle.
EvidenceEmerging: primarily preclinical / limited human dataEmerging: primarily preclinical / limited human data
Common side effectsInjection site reaction, skin irritation (topical), mild flushingInjection site irritation, mild nausea

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking GHK-Cu or KPV? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

GHK-Cu

  • Day 1–14 The first two weeks are groundwork
  • Day 14–28 Texture tends to move first
  • Day 28–56 This is where results tend to show
  • Day 56–84 Weeks 8–12: time for an honest look
  • Day 84+ Past the studied window — your read now

Every card for GHK-Cu, with its sources

KPV

  • Day 1–7 Week one: your starting point
  • Day 7–21 Users often report a calmer gut
  • Day 21–42 Some report calmer skin
  • Day 42–56 Weeks 6 to 8: taking stock

Every card for KPV, with its sources

Together or one or the other

GHK-Cu and KPV are a common stack: they’re together in the KLOW stack.

  • KLOW: GLOW plus KPV — four repair peptides in one vial (KPV, BPC-157, TB-500 and GHK-Cu).

Questions people ask

How long do GHK-Cu and KPV last?

The half-life of GHK-Cu is not measured in humans (breaks down quickly in plasma in rat and lab studies). The half-life of KPV is not measured: no half-life for KPV has been published, in people or animals.

How often are GHK-Cu and KPV taken?

GHK-Cu: daily. Routes: SubQ injection, topical application, IM injection. KPV: daily. Routes: SubQ injection, oral.

How are GHK-Cu and KPV dosed in research?

The research range for GHK-Cu is 1–2 mg. The research range for KPV is 100–300 mcg. Studied in research — not a recommendation.

What are the common side effects of GHK-Cu and KPV?

For GHK-Cu, the library lists: injection site reaction, skin irritation (topical), mild flushing. For KPV: injection site irritation, mild nausea.

Are GHK-Cu and KPV taken together?

GHK-Cu and KPV are a common stack: they’re together in the KLOW stack.

Each one in full

Track it in the app

PepVault for iPhone

Taking GHK-Cu or KPV? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo